MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, RGNX made $170,441K in revenue. -$193,824K in net income. Net profit margin of -113.72%.

Income Overview

Revenue
$170,441K
Net Income
-$193,824K
Net Profit Margin
-113.72%
EPS
-$3.76
Unit: Thousand (K) dollars
Revenue Breakdown
    • License And Service
    • Service

Income Statement
2025-12-31
Revenues
170,441
Cost of license and royalty revenues
20,298
Research and development
228,299
General and administrative
82,863
Other operating expenses
-179
Total operating expenses
331,639
Loss from operations
-161,198
Interest income from licensing
83
Investment income
12,245
Interest expense
45,008
Total other income (expense)
-32,680
Net loss
-193,878
Unrealized gain on available-for-sale securities, net
54
Total other comprehensive income
54
Comprehensive loss
-193,824
Basic EPS
-3.76
Diluted EPS
-3.76
Basic Average Shares
51,573,000
Diluted Average Shares
51,573,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Unrealized gain onavailable-for-sale securities, net$54K Comprehensive loss-$193,824K Total othercomprehensive income$54K Net loss-$193,878K License And Service$156,267K Service$14,174K Loss from operations-$161,198K Total other income(expense)-$32,680K Revenues$170,441K Investment income$12,245K Interest income fromlicensing$83K Total operatingexpenses$331,639K Interest expense$45,008K Research and development$228,299K General andadministrative$82,863K Cost of license androyalty revenues$20,298K Other operatingexpenses-$179K

REGENXBIO Inc. (RGNX)

REGENXBIO Inc. (RGNX)